Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Venous Thromboembolism”

59 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 59 results

Not applicableStudy completedNCT03977870
What this trial is testing

Identification of New Genetic Markers for the Risk of Recurrence of Venous Thromboembolism by Whole Genome Analysis

Who this might be right for
Venous Thromboembolism (VTE)
Assistance Publique Hopitaux De Marseille 843
Large-scale testing (Phase 3)Study completedNCT00740493
What this trial is testing

Prolonged Anticoagulation After a First Episod of Idiopathic Proximal Deep Vein Thrombosis (PADIS TVP)

Who this might be right for
Recurrent Venous ThromboembolismIdiopathic Deep Vein Thrombosis
University Hospital, Brest 104
Large-scale testing (Phase 3)Study completedNCT00740883
What this trial is testing

Extended Duration of Oral Anticoagulant Therapy After a First Episode of Idiopathic Pulmonary Embolism: a Randomized Controlled Trial. "PADIS-PE" Study.

Who this might be right for
Pulmonary Embolism
University Hospital, Brest 374
Not applicableLooking for participantsNCT07083609
What this trial is testing

Treatment Outcomes of Direct Oral Anticoagulants in Cerebral Venous Thrombosis in Vietnam

Who this might be right for
Cerebral Venous Thrombosis
Hieu Trung Dinh 69
Not applicableUnknownNCT01382550
What this trial is testing

Prevention of Thrombosis Recurrence in Patients With Low Circulating Levels of Antithrombin.

Who this might be right for
Venous Thrombosis
Federico II University 900
Not applicableLooking for participantsNCT07016542
What this trial is testing

Cohort for Monitoring Patients With Venous Thromboembolic Disease

Who this might be right for
Venous Thromboembolic Disease
University Hospital, Rouen 2,000
Not applicableEnded earlyNCT00428441
What this trial is testing

D-dimer to Predict Recurrence in Patients With Multiple Episodes of Venous Thromboembolism

Who this might be right for
Venous Thromboembolism
Università degli Studi dell'Insubria 73
Not applicableStudy completedNCT03214172
What this trial is testing

Characterizing Recurrent Thromboembolism, Major Bleeding and All-Cause Death in Patients With Cancer-Associated Thromboembolism Treated With Rivaroxaban

Who this might be right for
Venous Thromboembolism
Bayer 1,000
Large-scale testing (Phase 3)Study completedNCT00937820
What this trial is testing

Prevention of Recurrence of Venous Thromboembolism in Patients With a History of Venous Thromboembolism

Who this might be right for
Venous Thromboembolism
Astellas Pharma Inc 87
Not applicableUnknownNCT05229471
What this trial is testing

Management of Recurrent Venous Thromboembolism During Anticoagulant Treatment in Cancer Patients - a Prospective Cohort Study

Who this might be right for
CancerVenous ThromboembolismRecurrence
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 220
Large-scale testing (Phase 3)Ended earlyNCT00182247
What this trial is testing

D-Dimer and IPG for Recurrent Thrombosis (DIRECT)

Who this might be right for
Deep Vein ThrombosisPulmonary Embolism
Hamilton Health Sciences Corporation 600
Not applicableStudy completedNCT02742623
What this trial is testing

A Non-interventional Study on Xarelto for Treatment of Venous Thromboembolism (VTE) and Prevention of Recurrent VTE in Patients With Active Cancer

Who this might be right for
Venous Thrombosis and Pulmonary Embolism
Bayer 528
Not applicableStudy completedNCT04979780
What this trial is testing

Observational Studies in Cancer Associated Thrombosis for Rivaroxaban - United States Cohort

Who this might be right for
Treatment of Venous Thromboembolism in Cancer PatientsProphylaxis of Recurrent Venous Thromboembolism in Cancer Patients
Bayer 3,708
Post-approval studies (Phase 4)Study completedNCT01828697
What this trial is testing

Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in Pregnancy

Who this might be right for
Deep Venous ThrombosisPulmonary Embolism
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 1,110
Not applicableWithdrawnNCT05536791
What this trial is testing

A Study in Europe Based on Medical Records That Looks at the Safety of Dabigatran in Children Below 2 Years of Age Who Have Had a Blood Clot and Are at Risk of Developing Another Blood Clot

Who this might be right for
Venous Thromboembolism
Boehringer Ingelheim
Not applicableEnded earlyNCT05966740
What this trial is testing

A Study in the United Sates That Looks at the Safety and Effectiveness of Pradaxa Pellets in Children Aged 3 Months to Less Than 12 Years Who Need Treatment of a Blood Clot or Who Have Had a Blood Clot and Are at Risk of Developing Another Blood Clot

Who this might be right for
Venous Thromboembolism
Boehringer Ingelheim 6
Not applicableLooking for participantsNCT06372730
What this trial is testing

Residual Pulmonary Vascular Obstruction Index Computed with Ventilation/perfusion SPECT/CT Imaging to Predict the Risk of Venous Thromboembolism Recurrence in Patients with Pulmonary Embolism (PRONOSPECT)

Who this might be right for
Pulmonary EmbolismVenous Thromboembolism
University Hospital, Brest 665
Not applicableStudy completedNCT00720915
What this trial is testing

D-dimer to Select Patients With First Unprovoked Venous Thromboembolism Who Can Have Anticoagulants Stopped at 3 Months

Who this might be right for
Deep Vein ThrombosisPulmonary Embolism
McMaster University 410
Post-approval studies (Phase 4)Study completedNCT04168203
What this trial is testing

Extended-Duration Low-Intensity Apixaban to Prevent Recurrence in High-Risk Patients With Provoked Venous Thromboembolism

Who this might be right for
Deep Vein ThrombosisPulmonary EmbolismVenous Thromboembolism
Brigham and Women's Hospital 600
Not applicableLooking for participantsNCT06894576
What this trial is testing

Development of a Risk Stratification Score for Recurrent Venous Thromboembolism and Treatment-related Clinically Relevant Bleeding in Patients With Cancer-associated Thrombosis

Who this might be right for
Cancer-associated Thrombosis
Ottawa Hospital Research Institute 1,000
Load More Results